Literature DB >> 35015241

Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Martine Froukje van der Kamp1, Gyorgy Bela Halmos2, Victor Guryev3, Peter Laszlo Horvatovich4, Ed Schuuring5, Bernardus Franciscus Augustinus Maria van der Laan6, Bert van der Vegt5, Boudewijn Evert Christiaan Plaat2, Cornelia Johanna Verhoeven2.   

Abstract

BACKGROUND: In recent clinical practice, an increasing number of elderly patients suffering from head and neck squamous cell carcinoma (HNSCC) of unknown pathophysiology is observed. The majority of HNSCC patients can roughly be divided into three subcategories. First, a small group of young patients who present with variants of genomic aberrations and inheritable diseases like Fanconi anaemia. Second, an increasing population of HPV-related HNSCCs that are regarded as genomic stable tumours with a more favourable prognosis. Though HPV-related tumours used to be more common among younger males, a notable rise in the elderly population is observed. The third subcategory, that of HPV-negative tumours, has been shown to be more heterogeneous with involvement of a variety of oncogenic pathways related to lifestyle factors like smoking and alcohol consumption, often seen in middle-aged males. Some of these pathways could be related to age, such as TP53 alterations, EGFR activation, apoptotic pathway alterations and field cancerization.
CONCLUSIONS: In this narrative review, we provide an overview of established and newly discovered age-specific pathophysiological mechanisms underlying HNSCC. We propose a fourth subcategory of patients with a suspected different pathophysiology: elderly (HPV-negative) HNSCC patients without a history of tobacco and alcohol consumption. In this subcategory, carcinogenesis seems to be a multi-step process based on genomic instability, immunosenescence, cell cycle disruption and telomere shortening. To conclude, we discuss suggestions for future research to fill the knowledge gap about age-dependent HNSCC carcinogenesis.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Age-specific factors; Ageing; Epigenetics; Head and neck squamous cell carcinoma; Immunosenescence; Oncogenic pathways; Pathophysiology; Tumour biology

Mesh:

Year:  2022        PMID: 35015241     DOI: 10.1007/s13402-021-00655-4

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  107 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

Authors:  Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu
Journal:  Lancet Oncol       Date:  2016-02-27       Impact factor: 41.316

Review 3.  Treatment of head and neck cancer in the elderly.

Authors:  Stefan Hartmann; Jennifer R Grandis
Journal:  Expert Opin Pharmacother       Date:  2016-08-16       Impact factor: 3.889

Review 4.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 5.  Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

Authors:  Farshid Dayyani; Carol J Etzel; Mei Liu; Chung-Han Ho; Scott M Lippman; Anne S Tsao
Journal:  Head Neck Oncol       Date:  2010-06-29

6.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 7.  Head and neck squamous cell carcinoma in young patients.

Authors:  Hester S van Monsjou; Volkert B Wreesmann; Michiel W M van den Brekel; Alfons J M Balm
Journal:  Oral Oncol       Date:  2013-10-06       Impact factor: 5.337

8.  Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer.

Authors:  Thomas T A Peters; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Gyorgy B Halmos
Journal:  Ann Surg Oncol       Date:  2013-11-19       Impact factor: 5.344

Review 9.  The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks.

Authors:  Jan R Aunan; William C Cho; Kjetil Søreide
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.